Timing of tocilizumab administration under the guidance of il-6 in car-t therapy for r/r acute lymphoblastic leukemia

HIGHLIGHTS

• who: Yinqiang Zhang from the Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China have published the research: Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia, in the Journal: (JOURNAL)
• what: In the study , all participants were patients with ALL, and their baseline conditions are presented in Table 1 and analyzed between subgroups.
• how: All measurement data were described using median and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.